Neutralizing Protease Nexin-1 in hemophilia patients on emicizumab improves thrombin generation - Université de Paris - Faculté de Santé
Journal Articles Thrombosis Research Year : 2024

Neutralizing Protease Nexin-1 in hemophilia patients on emicizumab improves thrombin generation

Abstract

No abstract available
Fichier principal
Vignette du fichier
2024-ThrombRes-Letter-PN-1-hemophilia-emicizumab.pdf (2.62 Mo) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-04724007 , version 1 (07-10-2024)

Identifiers

Cite

Véronique Arocas, Laurence Venisse, Yacine Boulaftali, Stéphane Loyau, Claire Flaujac, et al.. Neutralizing Protease Nexin-1 in hemophilia patients on emicizumab improves thrombin generation. Thrombosis Research, 2024, Online ahead of print. ⟨10.1016/j.thromres.2024.109174⟩. ⟨hal-04724007⟩
46 View
9 Download

Altmetric

Share

More